Ratio Therapeutics, Inc. — SEC Form D Filing

Ratio Therapeutics, Inc. filed an SEC Form D on July 31, 2026, reporting $70.00M raised in Pharmaceuticals.

Form D filing details

Filing
SEC Form D
Filing date
July 31, 2026
Amount reported
$70.00M
Round stage
Series B+
Industry
Pharmaceuticals
Website
https://ratiotherapeutics.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Drug development for complex diseases often suffers from a lack of precise and quantifiable data to optimize therapeutic ratios and efficacy.

Solution

Ratio Therapeutics, Inc. provides advanced analytical platforms and services to pharmaceutical companies, enabling them to precisely measure and optimize the therapeutic ratios of their drug candidates for improved patient outcomes.

Why now

The specific timing catalyst for Ratio Therapeutics is unclear from available information.

Source: SEC EDGAR Form D filing